NIH-funded research R01 grant

Understanding how neurotransmitter transporters work and their interaction with drugs

Official title: Functional Dynamics of Neurotransmitter:Sodium Symporters (NSSs)

Funded at Columbia University Health Sciences · NIH-10826268 · Data updated 2026-11-12

This study is looking at how certain proteins in our brain help move important chemicals like serotonin and how different medications can change their behavior, which could lead to better treatments for conditions like ADHD.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 12, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$631,373
NIH project number1R01MH134473-01A1
Project IDNIH-10826268 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals diagnosed with ADHD or related conditions that involve serotonin dysregulation.

Less likely to help

Patients with conditions unrelated to neurotransmitter transport or those not affected by serotonin levels may not receive benefit from this research.

What this research studies

This research investigates the functional dynamics of neurotransmitter:sodium symporters (NSS), which are crucial for the transport of neurotransmitters like serotonin. By employing a combination of functional, spectroscopic, and computational methods, the study aims to uncover how these transporters operate, particularly focusing on how psychoactive drugs influence their activity. Patients may benefit from insights gained about the mechanisms of drug action and potential new therapeutic targets for conditions like ADHD. The research emphasizes the importance of understanding the structural changes and dynamics of these transporters in relation to drug binding and transport processes.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for conditions like ADHD by enhancing our understanding of how drugs interact with neurotransmitter transporters.

How similar studies have gone: Previous research has shown success in understanding neurotransmitter transport mechanisms, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Quick, Matthias — Columbia University Health Sciences
  • Study coordinator: Quick, Matthias

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.